Resultados y reacciones adversas en pacientes tratados con Heberprot-P® en la comunidad

Hernández Cañete, Carlos Manuel; Jácome Ruiz, Rogelio; Iturralde Mc Farlen, Lourdes; Sánchez Montiel, María Elena.
Rev. cuba. angiol. cir. vasc ; 18(1): 35-42, ene.-jun. 2017. ilus, tab
Artículo en Español | LILACS, CUMED | ID: biblio-844804

Documentos relacionados

  1. Resultados y reacciones adversas en pacientes tratados con Heberprot-P® en la comunidad
  2. Intralesional epidermal growth factor therapy in recalcitrant diabetic foot ulcers.
  3. Stem Cell Treatment for Diabetic Foot Ulcers: A Meta-analysis of Randomized Clinical Trials.
  4. Evaluation of the safety and healing potential of a fibroin-aloe gel film for the treatment of diabetic foot ulcers.
  5. Outcomes of Chronically Anticoagulated Patients Undergoing Split-Thickness Skin Grafting for Diabetic Foot Ulcers.
  6. Perilesional injections of human platelet lysate versus platelet poor plasma for the treatment of diabetic foot ulcers: A double-blinded prospective clinical trial.
  7. Based on Clinical Research Matrix Metalloprotease (MMP) Inhibitors to Promote Diabetic Wound Healing.
  8. Guidelines on interventions to enhance healing of foot ulcers in people with diabetes (IWGDF 2023 update).
  9. Further evidence that wound size and duration are strong prognostic markers of diabetic foot ulcer healing.
  10. Management of diabetic foot ulcers using topical probiotics in a soybean-based concentrate: a multicentre study.